Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Opens Boston R&D Center

Premium

Britain’s AstraZeneca has announced the opening of AstraZeneca R&D Boston, the company’s third research facility in North America.

 

The $100 million research center will employ 130 scientists specializing in infectious diseases and cancer. Additional research will focus on high-throughput screening technologies that enable novel, scientific approaches to pharmaceutical research.

 

Scientists at the facility will couple genomics with molecular biology in an effort to identify potential drug targets.

 

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.